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A recent preclinical study has shown that not only
maternal smoking but also grandmaternal smoking is
associated with elevated pediatric asthma risk. Using a
well-established rat model of in utero nicotine
exposure, Rehan et al. have now demonstrated
multigenerational effects of nicotine that could
explain this ‘grandmother effect’. F1 offspring of
nicotine-treated pregnant rats exhibited asthma-like
changes to lung function and associated epigenetic
changes to DNA and histones in both lungs and
gonads. These alterations were blocked by co-
administration of the peroxisome proliferator-activated
receptor-g agonist, rosiglitazone, implicating
downregulation of this receptor in the nicotine
effects. F2 offspring of F1 mated animals exhibited
similar changes in lung function to that of their
parents, even though they had never been exposed
to nicotine. Thus epigenetic mechanisms appear to
underlie the multigenerational transmission of a
nicotine-induced asthma-like phenotype. These
findings emphasize the need for more effective
smoking cessation strategies during pregnancy, and
cast further doubt on the safety of using nicotine
replacement therapy to reduce tobacco use in
pregnant women.
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Background
The negative health effects of tobacco use in adult smo-
kers are well established [1]. On average, smoking leads
to more than 400,000 premature deaths in the United
States each year, with an overall decrease in life expec-
tancy of 14 years. The major adverse health conse-
quences of smoking include cancer, cardiovascular
disease and respiratory disorders. Since many women
continue to smoke during pregnancy, the negative
impact of tobacco can begin before birth [2]. Maternal
smoking is now the single most important preventable
risk factor for Sudden Infant Death Syndrome, which
results from developmental delays in the neural control
of cardiopulmonary function [1,2]. Children of smokers
are also more prone to respiratory diseases, such as
asthma. One surprising finding is that a grandmother’s
tobacco use is associated with increased risk of early
childhood asthma, even if the mother did not smoke
while pregnant [3]. Rehan et al. [4] have recently used a
well-established rat model of in utero nicotine exposure
to determine the possible mechanisms underlying this
clinical observation (Figure 1). They found that maternal
nicotine exposure exerted adverse effects on lung devel-
opment, not only for the immediate offspring but also
for the next generation. They also identified epigenetic
mechanisms involved in this multigenerational transmis-
sion. This paper will review these groundbreaking find-
ings and discuss their potential clinical implications.
Transgenerational transmission of nicotine effects
Within recent years, fundamental assumptions about
genetic inheritance have been revisited [5,6]. In addition
to classical Mendelian genetics, the environment has
been shown to contribute to inherited characteristics by
placing epigenetic tags on DNA or associated histones
that result in modified gene expression. In particular,
the prenatal environment can result in reprogramming
of the epigenome, as demonstrated by Rehan et al. [4].
They showed that acute daily injections of nicotine
throughout pregnancy led to epigenetic modifications of
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lung tissue in the F1 offspring (Figure 1), with a result-
ing asthma-like phenotype. When F1 rats were mated,
similar changes in lung function were observed in their
F2 offspring, even though they had never been exposed
to nicotine. Nicotine induction of the asthma phenotype
was found to result from a downregulation of mesench-
ymal peroxisome proliferator-activated receptor-g
(PPARg), which plays a critical role in the development,
homeostasis and repair of the lung [7]. Rosiglitazone, a
PPARg agonist, completely prevented the alterations in
lung function, and in H3 acetylation of lung histones,
when co-administered with nicotine to the pregnant
dam [4].
Although the F2 rats had never been exposed to nico-
tine, their primordial germ cells were potential targets
while the F1 parents were in utero. The finding of nico-
tine-induced epigenetic changes in both ovarian and tes-
ticular tissues from F1 generation rats provides support
for this as a possible mechanism for functional changes
observed in F2 offspring. Whereas H4 histone acetyla-
tion was increased in the gonads of both sexes, DNA
methylation was increased in testes but decreased in
ovaries. All of these epigenetic changes were eliminated
by rosiglitazone, implicating the downregulation of
PPARg as a more universal mechanism of nicotine-
induced changes to the epigenome, impacting germ cells
as well as lung tissue.
In utero nicotine exposure resulted in alterations to
both the somatic and germ cell epigenome. However, the
nicotine-induced germ cell epigenetic changes were only
Figure 1 Multigenerational transmission of nicotine-induced effects. The diagram illustrates the experimental design and findings of Rehan
et al. [4]. Pregnant dams (F0 generation) are injected with nicotine or nicotine + rosiglitazone. The lungs and gonads of both male and female
offspring (F1 generation) of nicotine-treated dams exhibit epigenetic changes, and the lungs show an asthma-like functional phenotype (blue
nicotine-induced changes). These nicotine effects are not seen in the offspring of animals treated with nicotine + rosiglitazone. Offspring of F1
mated pairs (F2 generation) exhibit the same nicotine-induced changes to lung function as their parents, even though they were not exposed
to drug. It is not yet known whether the F2 offspring continue to exhibit alterations to the germ cell epigenome.
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examined in the gonads of F1 offspring. The true test of
whether nicotine can induce permanent epigenetic
changes to the germline, with resulting transgenerational
genetic inheritance, will require studies that look at germ
cells in the F2 offspring and lung function in subsequent
F3 and F4 generations. This issue notwithstanding, how-
ever, this preclinical study is critically important in that it
provides the first experimental evidence for multigenera-
tional effects of in utero nicotine exposure. Furthermore,
it provides a conceptual framework with which to under-
stand the novel clinical observation that grandmothers’
smoking patterns are as important as that of the mother
in determining pediatric lung function [3].
Future directions
Given the significant health risks to the offspring, effec-
tive smoking cessation strategies during pregnancy are
clearly needed. Whereas behavioral therapy does not
involve drug exposure to the fetus, it is not always effec-
tive. This has led some practitioners to advocate the use
of nicotine replacement therapy (NRT) as a smoking
cessation aid for pregnant women since it may reduce
the risk of low birth weight and preterm delivery [8].
However, the clinical community is divided on this
recommendation because of continued concerns about
efficacy and safety [9,10]. Preclinical investigators have
long argued that nicotine is a developmental teratogen
and should not be used as a treatment for pregnant
smokers [2,11]. The current finding of multigenerational
effects of in utero nicotine exposure will provide critical
support for this view.
Another issue that requires further assessment is
whether nicotine can induce more generalized epigenetic
changes, not only as a result of in utero exposure.
Primordial germ cells are also exposed to nicotine in
non-pregnant female and male smokers, and may
undergo epigenetic changes that are transmitted to future
progeny. Support for this concept comes from a recent
study that found cigarette smoke to induce specific dif-
ferences in the spermatozoal microRNA content of
human smokers as compared to non-smokers [12]. The
microRNAs that were differentially impacted mediate
pathways required for healthy sperm and normal embryo
development, suggesting a possible adverse impact of
smoking on these processes. Smoking may also produce
somatic changes in the developing brain during its criti-
cal adolescent period. Nearly all tobacco use begins in
childhood and adolescence, with almost 90% of adult
smokers reporting that they started smoking by the age
of 18 [13]. A growing clinical and preclinical literature
suggests that adolescent nicotine exposure produces
unique and long-term changes in neural structure, func-
tion and resulting behavior [11,14]. Similar PPARg-
mediated epigenetic mechanisms to those identified by
Rehan and colleagues [4] may underlie these unique
developmental effects of nicotine during adolescence.
Findings of widespread nicotine-induced changes to
the epigenome should stimulate further, more aggres-
sive, efforts to restrict youth access to tobacco products.
They may also lead to possible therapeutic strategies to
prevent or reverse the adverse impact of nicotine expo-
sure on the developing brain and periphery.
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